European Cardiovascular Experts’ STEMI (ECES) Summit WebCAST

WebCAST CME Disclosure

Please read this notice and click the acknowledgement
at the bottom of the page to continue.

Release Date:

March 30, 2009

Expiration Date:

March 30, 2011

Intended Audience:

• Cardiologists
• Interventional Cardiologists
• Emergency medicine specialists
• Prehospital care providers
• Critical care physicians and intensivists
• Hospitalists
• Hospital Pharmacists

Registration:

Enrollment for this WebCAST is complimentary, and clinicians are invited to participate in this CME-certified WebCAST and/or share this invitation with other colleagues, departmental staff members, and healthcare professionals.

Grantor Support:

Supported by an independent
educational grant from
The Medicines Company.

Accreditation Statement:

This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of The University of Massachusetts Medical School, Office of CME and CMEducation Resources, LLC. The University of Massachusetts Medical School is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation Statement:

The University of Massachusetts Medical School designates this educational activity for a maximum of 3.0 AMA PRA Category 1 Credit(s). Physicians should only claim credit commensurate with the extent of their participation in the activity.

Policy on Faculty & Provider Disclosure:

It is the policy of the University of Massachusetts Medical School to ensure fair balance, independence, objectivity and scientific rigor in all activities. All faculty participating in CME activities sponsored by the University of Massachusetts Medical School are required to present evidence-based data, identify and reference off-label product use and disclose all relevant financial relationships with those supporting the activity or others whose products or services are discussed. Faculty disclosure will be provided in the activity materials.

Faculty Disclosures:

Jonathan Hill, MD
No significant relationships to disclose

Prof. Dr. Christian Hamm, MD
Grants for educational activities and served as an advisor to GlaxoSmithKline,
Medtronic, CV Therapeutics, The Medicines Company, sanofi-aventis, Abbott,
Boehringer Ingelheim, Pfizer and Eli Lilly and Company
Grants for clinical research from Merck, Siemens, and Boston Scientific

Prof. Nicolas Danchin, MD, FESC
Research grants, speaker fees, advisory committees for: Astra-Zeneca,
BMS, Boehringer-Ingelheim, Eli-Lilly, GSK, MSD, Novartis, Pfizer,
sanofi-aventis, Servier, The Medicines Company

Giulio Guagliumi, MD
Consultant Agreement: Boston Scientific, CardioSpectra
Advisor to Volcano
Research Grants from: Abbott Vascular, Medtronic, Boston Scientific, LightLab, Labcoat

Prof. Frans Van de Werf, MD, PhD
Research grant support as a principal investigator from Boehringer Ingelheim and sanofi-aventis
Honoraria as a speaker for Boehringer Ingelheim
Honoraria as an advisory board member for GlaxoSmithKline and sanofi-aventis

Roxana Mehran, MD
Clinical Research Support: The Medicines Company, and Boston Scientific
Educational Research Support: The Medicines Company, Boston Scientific, Abbott, Medtronic and Cordis

Program Faculty:

Co-Chairman (U.K.)
Jonathan Hill, MD
Senior Lecturer and Cardiology Consultant
Cardiovascular Division
King's College School of Medicine
at Denmark Hill
London , United Kingdom

Co-Chairman (Germany)
Prof. Dr. Christian Hamm, MD
Professor and Director
Department of Cardiology
Kerckhoff-Klinick Center
Bad Nauheim, Germany

Co-Chairman (France)
Prof. Nicolas Danchin, MD, FESC
Professor of Medicine
Department of Cardiology
Hôpital Européen Georges Pompidou
Paris, France

Co-Chairman (Italy)
Giulio Guagliumi, MD
Interventional Catheterization Laboratory
Ospedali Riuniti Di Bergamo
Bergamo, Italy

Prof. Frans Van de Werf, MD, PhD
Professor and Chairman
Department of Cardiology
University Hospitals Leuven
Belgium

Roxana Mehran, MD
Director of Clinical Research and the Data Coordinating & Analysis Center
Cardiovascular Research Foundation
Associate Professor of Medicine
Columbia University Medical Center (CUMC)
Director of Outcomes Research, Data Coordination and Analysis
Center for Interventional Vascular Therapy at CUMC
New York, New York

Educational Objectives:

Participants in this CME-certified WebCAST will:

• Learn to apply evidence from recent landmark trials and international guide lines to new practice paradigms for managing STEMI and high risk ACS.
• Learn to identify signs, symptoms, and prognostic features of high risk ACS and STEMI.
• Learn to assess and implement optimal pharmacologic interventions consistent with the latest evidence and national guidelines.
• Learn to characterize, identify, and evaluate the safety, efficacy, and side effects of myriad therapeutic options used for STEMI and high risk ACS, including, aspirin, antiplatelet agents, direct thrombin inhibitors, UFH, LMWHs, and factor Xa inhibitors.
• Learn to understand the specific advantages and potential disadvan tages of currently pharmacologic agents used to reduce ischemic and bleeding end points in the setting of cardiovascular emergencies.
• Learn to discuss and assess the impact that new trials and AHA/ACC Guidelines are likely to have on future management of patients with STEMI and high risk ACS.
  

Disclaimer:

Copyright © 2009 by Pharmatecture, LLC and CMEducation Resources, LLC All rights reserved.

Reproduction, distribution, or translation without express written permission is strictly prohibited.

Content on this webcast reflects the opinions, output, and analyses of experts, investigators, educators, and clinicians whose activities for, while independent, are commercially supported by the sponsor noted at the start of each activity.
Content on this webcast is not meant to be, nor substitute for national guidelines or recommendations generated by professional, academic societies, colleges, or associations.

Content on this webcast is intended for educational value only. Its contents, analyses, and any recommendation made herein are intended to make scientific information and opinion available to health professionals, to stimulate thought, and further investigation. This webcast is not designed nor is any aspect of the contents here intended to provide advice regarding medical diagnosis or treatment for any individual case. Any decisions regarding diagnosis and/or management of any individual patient or group of patients should be made on individual basis after having consulted appropriate sources, whether they be appropriate consultants and/or guidelines and recommendations issued by national organizations, professional societies, governmental health organizations, or similar bodies. This webcast is not intended for use by the layman.

Opinions expressed herein are not necessarily those of Pharmatecture, LLC, CMEducation Resources, LLC, program supporters or accreditors, but reflect the opinions and analyses of the experts who have authored the material. Mention of products or services does not constitute endorsement. Clinical, legal, financial, and other comments are offered for general guidance only; and professional counsel should be sought for all specific situations.

Copyright © 2008 All rights reserved